Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dejah Judelson

Vascular Surgery Worcester, MA Medical Doctor

NPI 1992068274 CMS profile 932418

55 Lake Ave N, Worcester, MA 01655

Open in the dashboard

General payments

$92,415

114 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$25,315 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Dejah Judelson of Worcester, MA is reported in the CMS Open Payments database as having received $92,415 across 114 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $25,315 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46,817 50
2024 General $11,295 19
2023 General $17,600 18
2022 General $11,057 16
2021 General $5,508 10
2019 General $138 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dejah Judelson
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Dejah Judelson were reported at $46,817. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Dejah Judelson Vascular Surgery median Middle half National median
2019 $138 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $5,508 $471 $158–$1,421 $132
2022 $11,057 $725 $222–$2,183 $149
2023 $17,600 $836 $257–$2,440 $160
2024 $11,295 $909 $252–$2,619 $164
2025 $46,817 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $41,880 15 payments
  2. Penumbra, Inc. $31,733 35 payments
  3. Medtronic, Inc. $7,399 16 payments
  4. Shockwave Medical, Inc $7,002 14 payments
  5. Cook Medical LLC $3,556 25 payments
  6. Abbott Laboratories $455 3 payments
  7. Inari Medical, Inc. $302 3 payments
  8. Bard Peripheral Vascular, Inc. $59 1 payment
  9. Boston Scientific Corporation $22 1 payment
  10. LeMaitre Vascular, Inc. $9 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64,620 17 payments
  2. Consulting Fee $13,250 6 payments
  3. Travel and Lodging $8,621 29 payments
  4. Food and Beverage $5,924 62 payments
Products named General payments · program years 2019–2025
  1. Indigo System $26,812 26 payments
  2. Zilver Vena $21,853 12 payments
  3. Zilver PTX $14,655 11 payments
  4. VENASEAL $7,164 12 payments
  5. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $6,384 8 payments
  6. RUBY Coil $4,204 2 payments
  7. COOK $2,729 2 payments
  8. Penumbra System $718 7 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $604 4 payments
  10. FLOWTRIEVER CATHETER, S $603 6 payments
  11. Other $2,418 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 128 billing codes

Paid by Medicare

$181,361

Of which drugs: $79

Medicare patients

1,254

Average age 74

Services billed

2,754

595 women, 659 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Ischemic heart disease 44%
Chronic kidney disease 40%
Diabetes 39%
Heart failure 30%
Depression 30%
Atrial fibrillation 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 14 750 $79

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record